In the era of A.I. agents, many Silicon Valley programmers are now barely programming. Instead, what they’re doing is deeply, ...

Iran continues to launch missile and drone strikes across several Middle East countries as Trump warns over the Strait of ...

The Big Ten wants clearer guidelines on tampering after the NCAA sent out a memo promising strict punishment for rule breakers ...

NASA's moon landing program delay represents the latest in in technical, budgetary, workforce and public perception ...

Artificial intelligence and the internet of things are reshaping enterprise strategy across industries. From predictive ...

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2025 Earnings Call Transcript March 12, 2026 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.22551.

Good day, and welcome to the Q1 FY 2026 Adobe Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Doug Clark, Vice President of ...

This incentive structure helps explain why Peoples Gas continues to expand its costly Pipe Retirement Program.

In some cases, DEI efforts were too generic, poorly contextualized, or implemented in ways that created resistance rather than commitment Many organizations say the right things, yet employees’ day-to ...

Q4 2025 Earnings Call March 12, 2026 9:00 AM EDTCompany ParticipantsKelly Harvey - Director of Investor RelationsJames Zizelman ...

G&A Expenses -- $13.8 million in the fourth quarter, of which $5.6 million was non-cash stock-based compensation; annual G&A ...